Αποτελέσματα Αναζήτησης
18 Δεκ 2023 · Cannabis, also known as marijuana, has been approved for medical use in 38 states (including the District of Columbia) so far, and is used to treat symptoms associated with diseases such as, for...
- U.S. Medical Marijuana Retail Sales 2018-2023
Number of medical cannabis prescribers in Denmark Q4 2023,...
- Cannabis in Europe
Premium Statistic Medical cannabis market value in Italy...
- U.S. Medical Marijuana Retail Sales 2018-2023
23 Σεπ 2021 · Between 2010 and 2019, past-month prevalence of cannabis use increased by 27% in European adults (from 3·1 to 3·9%), with most pronounced relative increases observed among 35-64 year-olds. In 13 out of 26 countries, over 20% of all past-month users reported high-risk use patterns.
29 Σεπ 2020 · Most patients reported cannabis experience prior to seeking medical certification (66.9%). The top three mutually exclusive primary medical conditions reported were unspecified chronic pain (38.8%), anxiety (13.5%) and post-traumatic stress disorder (PTSD) (8.4%).
2 ημέρες πριν · Premium Statistic Medical cannabis market value in Italy 2020-2030, by segment Premium Statistic Share of cannabis for medical use in Italy in 2022, by cannabis format
The Medical Cannabis market worldwide is projected to grow by 2.10% (2024-2029) resulting in a market volume of US$22.46bn in 2029.
Cannabis remains by far the most commonly consumed illicit drug in Europe. On this page, you can find the latest analysis of the drug situation for cannabis in Europe, including prevalence of use, treatment demand, seizures, price and purity, harms and more.
Thus, these surveys are an important source of epidemiologic data on changes in cannabis use and CUD in the US general population over time. Next, this review provides a brief summary of recent studies of the effects of state medical marijuana laws (MML) and state recreational marijuana laws (RML).
